Global Liquid Biopsy Market: Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

The Global Liquid Biopsy Market has been analyzed by countries (Americas, Europe, Asia Pacific, Middle East & Africa), By Countries (United States, Canada, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea).
HOUSTON - Jan. 27, 2023 - PRLog -- The Global Liquid Biopsy Market was valued at USD 2.2 Billion in the year 2021 backed by several initiatives to raise cancer awareness launched by governments and global health organizations over the last decade.

Developing economies such as India, China, South Korea, Brazil, Turkey, Russia, and South Africa are expected to provide potential growth opportunities for liquid biopsy market players. This can be attributed to these countries' higher cancer prevalence, large patient populations, improved healthcare infrastructure, rising disposable income, and growing medical tourism. Apart from the previously mentioned factors, the Asia Pacific region has emerged as an adaptable and business-friendly hub due to less stringent regulations and data requirements.

Scope of the Report
  • The report analyses the Liquid Biopsy Market by Value (USD Million).
  • The report analyses the Liquid Biopsy Market by Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Other Biomarkers Type).
  • The report analyses the Liquid Biopsy Market by Indication (Cancer, Prenatal Screening, Others Indication).
  • The report analyses the Liquid Biopsy Market by Product (Assay Kits, Instruments and Devices, Services).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Indication, and by biomarkers.
  • Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers, and acquisitions, and new Biomarker development. The companies analyzed in the report include Roche Holding AG, Abbott Laboratories, Illumina Inc, Biocartis, Guardant Health, QIAGEN, Thermo Fisher Scientific, Biocept, Inc, Bio-Rad Laboratories, and MDxHealth).
  • The report presents the analysis of the Liquid Biopsy market for the historical period of 2018-2021 and the forecast period of 2023-2028.

For more Information:

Derrick Samson

(Business Development Manager)

Address:  1321 Upland Dr. PMB 15832

Houston, Texas, 77043,


Mobile: +1 832 495 4885

Mail ID -

Derrick Samson
+1 832 495 4885
Source: » Follow
Email:*** Email Verified
Tags:Global Liquid Biopsy Market
Location:Houston - Texas - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share